These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28385504)

  • 21. Sulfonamides as Selective Na
    Weiss MM; Dineen TA; Marx IE; Altmann S; Boezio A; Bregman H; Chu-Moyer M; DiMauro EF; Feric Bojic E; Foti RS; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Huang H; Huang L; Jarosh M; Kornecook T; Kreiman CR; Ligutti J; La DS; Lin MJ; Liu D; Moyer BD; Nguyen HN; Peterson EA; Rose PE; Taborn K; Youngblood BD; Yu V; Fremeau RT
    J Med Chem; 2017 Jul; 60(14):5969-5989. PubMed ID: 28287723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. µ-Conotoxins Targeting the Human Voltage-Gated Sodium Channel Subtype Na
    McMahon KL; Tran HNT; Deuis JR; Craik DJ; Vetter I; Schroeder CI
    Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering of highly potent and selective HNTX-III mutant against hNa
    Zhang Y; Wang L; Peng D; Zhang Q; Yang Q; Li J; Li D; Tang D; Chen M; Liang S; Liu Y; Wang S; Liu Z
    J Biol Chem; 2021; 296():100326. PubMed ID: 33493520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na
    Luo G; Chen L; Easton A; Newton A; Bourin C; Shields E; Mosure K; Soars MG; Knox RJ; Matchett M; Pieschl RL; Post-Munson DJ; Wang S; Herrington J; Graef J; Newberry K; Sivarao DV; Senapati A; Bristow LJ; Meanwell NA; Thompson LA; Dzierba C
    J Med Chem; 2019 Jan; 62(2):831-856. PubMed ID: 30576602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico insight into voltage-gated sodium channel 1.7 inhibition for anti-pain drug discovery.
    Wang M; Li W; Wang Y; Song Y; Wang J; Cheng M
    J Mol Graph Model; 2018 Sep; 84():18-28. PubMed ID: 29793215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
    Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
    Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and mechanism of action of novel μ-conotoxin KIIIA analogues for inhibition of the voltage-gated sodium channel Na
    Zhao Z; Pan T; Chen S; Harvey PJ; Zhang J; Li X; Yang M; Huang L; Wang S; Craik DJ; Jiang T; Yu R
    J Biol Chem; 2023 Apr; 299(4):103068. PubMed ID: 36842500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin.
    Zhao F; Li X; Jin L; Zhang F; Inoue M; Yu B; Cao Z
    Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26891306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of hNaV1.7.
    Thomas-Tran R; Du Bois J
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5856-61. PubMed ID: 27162340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery and optimization of benzimidazoles as selective Na
    Brown AD; Bagal SK; Blackwell P; Blakemore DC; Brown B; Bungay PJ; Corless M; Crawforth J; Fengas D; Fenwick DR; Gray V; Kemp M; Klute W; Malet Sanz L; Miller D; Murata Y; Payne CE; Skerratt S; Stevens EB; Warmus JS
    Bioorg Med Chem; 2019 Jan; 27(1):230-239. PubMed ID: 30538065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.
    Suzuki S; Kuroda T; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Sugita R; Koishi R; Asano D; Tamaki K; Shinozuka T; Kobayashi H
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5419-23. PubMed ID: 26358159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping the interaction site for the tarantula toxin hainantoxin-IV (β-TRTX-Hn2a) in the voltage sensor module of domain II of voltage-gated sodium channels.
    Cai T; Luo J; Meng E; Ding J; Liang S; Wang S; Liu Z
    Peptides; 2015 Jun; 68():148-56. PubMed ID: 25218973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of N-(((1S,3R,5S)-adamantan-1-yl)methyl)-3-((4-chlorophenyl)sulfonyl)benzenesulfonamide as novel Nav1.8 inhibitor with analgesic profile.
    Song C; Qiu J; Luo M; Fu Y; Hu S; Liu W; Zhang D; Chen M; Cao Z; Yang X; Ke B
    Bioorg Med Chem Lett; 2024 Sep; 110():129862. PubMed ID: 38944398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
    Sun S; Cohen CJ; Dehnhardt CM
    Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Acyl-sulfonamide Na
    Safina BS; McKerrall SJ; Sun S; Chen CA; Chowdhury S; Jia Q; Li J; Zenova AY; Andrez JC; Bankar G; Bergeron P; Chang JH; Chang E; Chen J; Dean R; Decker SM; DiPasquale A; Focken T; Hemeon I; Khakh K; Kim A; Kwan R; Lindgren A; Lin S; Maher J; Mezeyova J; Misner D; Nelkenbrecher K; Pang J; Reese R; Shields SD; Sojo L; Sheng T; Verschoof H; Waldbrook M; Wilson MS; Xie Z; Young C; Zabka TS; Hackos DH; Ortwine DF; White AD; Johnson JP; Robinette CL; Dehnhardt CM; Cohen CJ; Sutherlin DP
    J Med Chem; 2021 Mar; 64(6):2953-2966. PubMed ID: 33682420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a Novel Class of State-Dependent Na
    Tanaka K; Kobayashi H; Suzuki S; Shibuya S; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Shinozuka T
    Chem Pharm Bull (Tokyo); 2020; 68(7):653-663. PubMed ID: 32612000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionalized Fullerene Targeting Human Voltage-Gated Sodium Channel, hNa
    Hilder TA; Robinson A; Chung SH
    ACS Chem Neurosci; 2017 Aug; 8(8):1747-1755. PubMed ID: 28586206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.
    Peschel A; Cardoso FC; Walker AA; Durek T; Stone MRL; Braga Emidio N; Dawson PE; Muttenthaler M; King GF
    J Med Chem; 2020 Nov; 63(21):12773-12785. PubMed ID: 33078946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of DS-1971a, a Potent, Selective Na
    Shinozuka T; Kobayashi H; Suzuki S; Tanaka K; Karanjule N; Hayashi N; Tsuda T; Tokumaru E; Inoue M; Ueda K; Kimoto H; Domon Y; Takahashi S; Kubota K; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Sakakura T; Takasuna K; Abe Y; Watanabe T; Kitano Y
    J Med Chem; 2020 Sep; 63(18):10204-10220. PubMed ID: 32392056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.